Allspring Global Investments
LBPH

Allspring Global Investments’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Allspring Global Investments’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,371
Closed -$7.62K – 2857
2023
Q3 		$7.62K Buy
+1,371
New +$8.83K ﹤0.01% 2639

Other funds holding LBPH

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allspring Global Investments's LBPH Position: Q4 2023 in Review

Allspring Global Investments sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2023, closing a stake of 1,371 shares — an estimated $7.62K sold.

Allspring Global Investments first reported a position in LBPH in Q3 2023 and held it in 1 quarter. The position peaked at $7.62K in Q3 2023. 52 funds tracked by Wall St. Rank hold LBPH as of Q4 2023.

  • Allspring Global Investments reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 1,371 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $7.62K.
  • Allspring Global Investments first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Allspring Global Investments's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $7.62K in Q3 2023.
  • 52 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.